Articles dans des revues avec comité de lecture (144)
  1. 117. Demonte, D., Van Lint, C., & Burny, A. (2002). La thérapie génique. Revue Médicale de Bruxelles, 23(4), A331-A334.
  2. 118. Merezak, C., Reichert, M., Van Lint, C., Kerkhofs, P., Portetelle, D., Willems, L., & Kettmann, R. (2002). Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. Journal of virology, 76(10), 5034-5042.
  3. 119. Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., De Launoit, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (2002). Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. Journal of virology, 76(21), 11091-11103.
  4. 120. Iordanskiy, S., Iordanskaya, T., Quivy, V., Van Lint, C., & Bukrinsky, M. (2002). B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-kappaB p65 subunit activity. Virology, 302(1), 195-206. doi:10.1006/viro.2002.1618
  5. 121. Gatot, J.-S., Callebaut, I., Van Lint, C., Demonte, D., Kerkhofs, P., Portetelle, D., Burny, A., Willems, L., & Kettmann, R. (2002). Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. Journal of virology, 76(16), 7956-7967.
  6. 122. Castellano, R., Van Lint, C., Peri, V., Veithen, E., Morel, Y., Costello, R., Olive, D., & Collette, Y. (2002). Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control. The Journal of biological chemistry, 277(45), 42841-42851. doi:10.1074/jbc.M207689200
  7. 123. Calomme, C., Nguyen, T. L.-A., De Launoit, Y., Kiermer, V., Droogmans, L., Burny, A., & Van Lint, C. (2002). Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression. The Journal of biological chemistry, 277(11), 8775-8789. doi:10.1074/jbc.M107441200
  8. 124. Quivy, V., & Van Lint, C. (2002). Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system. Biochemical pharmacology, 64(5-6), 925-934. doi:10.1016/S0006-2952(02)01152-8
  9. 125. Burny, A., Demonte, D., & Van Lint, C. (2001). Les gènes: moteurs de la vie et de la maladie. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 156(10-12), 533-544.
  10. 126. Bentires-Alj, M., Dejardin, E., Viatour, P., Van Lint, C., Froesch, B., Reed, J. C., Merville, M.-P., & Bours, V. (2001). Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene, 20(22), 2805-2813. doi:10.1038/sj.onc.1204343
  11. 127. Merezak, C., Pierreux, C., Adam, E., Lemaigre, F. P., Rousseau, G., Calomme, C., Van Lint, C., Christophe, D., Kerkhofs, P., Burny, A., Kettmann, R., & Willems, L. (2001). Suboptimal enhancer sequences are required for efficient Bovine Leukemia Virus propagation in vivo: implications for viral latency. Journal of Virology, 75(15), 6977-6988. doi:10.1128/JVI.75.15.6977-6988.2001
  12. 128. Van Lint, C. (2000). Role of chromatin in HIV-1 transcriptional regulation. Advances in pharmacology, 48, 121-160.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>